While higher AZGP1 levels were associated with reduced incidence of coronary heart disease and atherosclerosis in non-CKD patients (14, 15), higher AZGP1 levels were shown to correlate positively with CVD in ESRD patients (16). Here, AZGP1 is linked to chronic kidney disease.